Human papillomavirus 45 genetic variation and cervical cancer risk worldwide

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4514-4521

  Chen, Alyce A ^a   Heideman, Daniëlle A M ^b   Boon, Debby ^b   Gheit, Tarik ^a   Snijders, Peter J F ^b   Tommasino, Massimo ^a   Franceschi, Silvia ^a   Clifford, Gary M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; ASIA; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; EUROPE; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; MAJOR CLINICAL STUDY; NORTH AMERICA; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PACIFIC ISLANDS; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTH AFRICA; UTERINE CERVIX CANCER;

ALPHAPAPILLOMAVIRUS; CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH;

EID: 84896965460     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03534-13     Document Type: Article

References (45)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group. 2009. A review of human carcinogens-part B: biological agents. Lancet Oncol. 10:321-322. http://dx.doi.org/10.1016/S1470-2045(09)70096-8.
2. Baseman JG, Koutsky LA. 2005. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32(Suppl 1):S16-S24. http://dx.doi.org/10.1016/j.jcv.2004.12.008.
3. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93:1325-1330. http://dx.doi.org/10.1093/jnci/93.17.1325.
4. Gheit T, Cornet I, Clifford GM, Iftner T, Munk C, Tommasino M, Kjaer SK. 2011. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol. Biomarkers Prev. 20:1315-1321. http://dx.doi.org/10.1158/1055-9965.EPI-10-1187.
5. Sathish N, Abraham P, Peedicayil A, Sridharan G, Chandy G. 2005. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett. 229:93-99. http://dx.doi.org/10.1016/j.canlet.2005.04.026.
6. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 70:3159-3169. http://dx.doi.org/10.1158/0008-5472.CAN-09-4179.
7. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2959-2968.
8. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T. 2009. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 125:2609-2613. http://dx.doi.org/10.1002/ijc.24706.
9. Naghashfar ZS, Rosenshein NB, Lorincz AT, Buscema J, Shah KV. 1987. Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J. Gen. Virol. 68:3073-3079. http://dx.doi.org/10.1099/0022-1317-68-12-3073.
10. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79. http://dx.doi.org/10.1016/j.virol.2010.02.002.
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27. http://dx.doi.org/10.1016/j.virol.2004.03.033.
12. Clifford G, Franceschi S. 2008. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int. J. Cancer 122:1684-1685. http://dx.doi.org/10.1002/ijc.23282.
13. Guan P, Clifford GM, Franceschi S. 2013. Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies. Int. J. Cancer 132:248-250. http://dx.doi.org/10.1002/ijc.27663.
14. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int. J. Cancer 128:927-935. http://dx.doi.org/10.1002/ijc.25396.
15. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM. 2012. Human papillomavirus types in 115,789 HPVpositive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 131:2349-2359. http://dx.doi.org/10.1002/ijc.27485.
16. Chen Z, DeSalle R, Schiffman M, Herrero R, Burk RD. 2009. Evolutionary dynamics of variant genomes ofhumanpapillomavirus types 18, 45, and 97. J. Virol. 83:1443-1455. http://dx.doi.org/10.1128/JVI.02068-08.
17. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. 2011. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 6:e20183. http://dx.doi.org/10.1371/journal.pone.0020183.
18. Cornet I, Gheit T, Iannacone MR, Vignat J, Sylla BS, Del Mistro A, Franceschi S, Tommasino M, Clifford GM. 2013. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 108:240-244. http://dx.doi.org/10.1038/bjc.2012.508.
19. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
20. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527. http://dx.doi.org/10.1056/NEJMoa021641.
21. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Munoz N, Meijer CJ, Herrero R. 2003. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int. J. Cancer 107:127-133. http://dx.doi.org/10.1002/ijc.11350.
22. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on CancerHPVprevalence surveys: a pooled analysis. Lancet 366:991-998. http://dx.doi.org/10.1016/S0140-6736(05)67069-9.
23. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontaniere B, Snijders P, Meijer C, Franceschi S. 2005. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int. J. Cancer 113:483-489. http://dx.doi.org/10.1002/ijc.20600.
24. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S. 2006. Human papillomavirus infection in Shenyang City, People's Republic of China: a populationbased study. Br. J. Cancer 95:1593-1597. http://dx.doi.org/10.1038/sj.bjc.6603450.
25. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S. 2007. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int. J. Cancer 121:1306-1311. http://dx.doi.org/10.1002/ijc.22726.
26. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjanczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJ, Meijer CJ, Zatonski W, Franceschi S. 2008. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur. J. Cancer 44:557-564. http://dx.doi.org/10.1016/j.ejca.2007.12.001.
27. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M. 2008. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol. Biomarkers Prev. 17:1731-1738. http://dx.doi.org/10.1158/1055-9965.EPI-07-2796.
28. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S. 2009. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br. J. Cancer 101:202-208. http://dx.doi.org/10.1038/sj.bjc.6605140.
29. Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M. 2009. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine 27(Suppl 1):A30-A33. http://dx.doi.org/10.1016/j.vaccine.2008.12.028.
30. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygard M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S. 2010. Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 21:323-330. http://dx.doi.org/10.1007/s10552-009-9467-z.
31. Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJ, Heideman DA, van Kemenade FJ, Meijer CJ, Kordzaia D, Franceschi S. 2011. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol. 35:465-470. http://dx.doi.org/10.1016/j.canep.2010.12.006.
32. De Vuyst H, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S. 2012. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int. J. Cancer 131:949-955. http://dx.doi.org/10.1002/ijc.26470.
33. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, Bathija H, Heideman DA, van Kemenade FJ, Meijer CJ, Hosseini SJ, Franceschi S. 2012. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int. J. Cancer 131:E156-E161. http://dx.doi.org/10.1002/ijc.26488.
34. Aruhuri B, Tarivonda L, Tenet V, Sinha R, Snijders PJ, Clifford G, Pang J, McAdam M, Meijer CJ, Frazer IH, Franceschi S. 2012. Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev. Res. (Phila.) 5:746-753. http://dx.doi.org/10.1158/1940-6207.CAPR-11-0515.
35. Mbaye EH, Gheit T, Dem A, McKay-Chopin S, Toure-Kane NC, Mboup S, Tommasino M, Sylla BS, Boye CS. 2014. Human papillomavirus infection in women in four regions of Senegal. J. Med. Virol. 86:248-256. http://dx.doi.org/10.1002/jmv.23719.
36. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787. http://dx.doi.org/10.1128/JCM.40.3.779-787.2002.
37. Godinez JM, Heideman DA, Gheit T, Alemany L, Snijders PJ, Tommasino M, Meijer CJ, de Sanjose S, Bosch FX, Bravo IG. 2013. Differential presence of papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58. Infect. Genet. Evol. 13:96-104. http://dx.doi.org/10.1016/j.meegid.2012.09.011.
38. Hesselink AT, Berkhof J, Heideman DA, Bulkmans NW, van Tellingen JE, Meijer CJ, Snijders PJ. 2009. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int. J. Cancer 124:381-386. http://dx.doi.org/10.1002/ijc.23940.
39. Felsenstein J. 1989. Mathematics vs. evolution: mathematical evolutionary theory. Science 246:941-942. http://dx.doi.org/10.1126/science.246.4932.941.
40. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. 2013. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One 8:e72565. http://dx.doi.org/10.1371/journal.pone.0072565.
41. Ntova CK, Kottaridi C, Chranioti A, Spathis A, Kassanos D, Paraskevaidis E, Karakitsos P. 2012. Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in Greek women. Int. J. Mol. Sci. 13:1-17. http://dx.doi.org/10.3390/ijms13010001.
42. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM. 2012. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 86:6855-6861. http://dx.doi.org/10.1128/JVI.00483-12.
43. Chen AA, Heideman DAM, Boon D, Chen Z, Burk RD, De Vuyst H, Gheit T, Snijders PJF, Tommasino M, Franceschi S, Clifford GM. 2014. Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology 448:356-362. http://dx.doi.org/10.1016/j.virol.2013.10.033.
44. Liu Y, Chen JJ, Gao Q, Dalal S, Hong Y, Mansur CP, Band V, Androphy EJ. 1999. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J. Virol. 73:7297-7307.
45. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B. 2004. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J. Med. Virol. 74:107-116. http://dx.doi.org/10.1002/jmv.20153.